These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 1281212)
21. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation. Hahn YS; Hahn CS; Braciale TJ Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001 [TBL] [Abstract][Full Text] [Related]
22. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. Udaka K; Wiesmüller KH; Kienle S; Jung G; Walden P J Exp Med; 1995 Jun; 181(6):2097-108. PubMed ID: 7539039 [TBL] [Abstract][Full Text] [Related]
23. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies. Messaoudi I; LeMaoult J; Nikolić-Zugić J J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598 [TBL] [Abstract][Full Text] [Related]
24. The critical role of a solvent-exposed residue of an MHC class I-restricted peptide in MHC-peptide binding. Huard R; Dyall R; Nikolić-Zugić J Int Immunol; 1997 Nov; 9(11):1701-7. PubMed ID: 9418131 [TBL] [Abstract][Full Text] [Related]
25. CTL escape viral variants. I. Generation and molecular characterization. Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078 [TBL] [Abstract][Full Text] [Related]
26. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition. Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163 [TBL] [Abstract][Full Text] [Related]
27. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811 [TBL] [Abstract][Full Text] [Related]
28. Mimicry of native peptide antigens by the corresponding retro-inverso analogs is dependent on their intrinsic structure and interaction propensities. Nair DT; Kaur KJ; Singh K; Mukherjee P; Rajagopal D; George A; Bal V; Rath S; Rao KV; Salunke DM J Immunol; 2003 Feb; 170(3):1362-73. PubMed ID: 12538696 [TBL] [Abstract][Full Text] [Related]
29. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Matsumura M; Fremont DH; Peterson PA; Wilson IA Science; 1992 Aug; 257(5072):927-34. PubMed ID: 1323878 [TBL] [Abstract][Full Text] [Related]
30. Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides. Grandea AG; Bevan MJ Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2794-8. PubMed ID: 1557385 [TBL] [Abstract][Full Text] [Related]
31. Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner. Saito NG; Chang HC; Paterson Y J Immunol; 1999 May; 162(10):5998-6008. PubMed ID: 10229839 [TBL] [Abstract][Full Text] [Related]
32. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238 [TBL] [Abstract][Full Text] [Related]
33. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. Lipford GB; Hoffman M; Wagner H; Heeg K J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Schneck J; Maloy WL; Coligan JE; Margulies DH Cell; 1989 Jan; 56(1):47-55. PubMed ID: 2783386 [TBL] [Abstract][Full Text] [Related]
35. The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection. Young AC; Zhang W; Sacchettini JC; Nathenson SG Cell; 1994 Jan; 76(1):39-50. PubMed ID: 7506996 [TBL] [Abstract][Full Text] [Related]
36. Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes. Itoh T; Storkus WJ; Gorelik E; Lotze MT J Immunol; 1994 Aug; 153(3):1202-15. PubMed ID: 7517974 [TBL] [Abstract][Full Text] [Related]
37. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. Chen W; Khilko S; Fecondo J; Margulies DH; McCluskey J J Exp Med; 1994 Oct; 180(4):1471-83. PubMed ID: 7523572 [TBL] [Abstract][Full Text] [Related]
38. Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex. Corr M; Boyd LF; Frankel SR; Kozlowski S; Padlan EA; Margulies DH J Exp Med; 1992 Dec; 176(6):1681-92. PubMed ID: 1281216 [TBL] [Abstract][Full Text] [Related]
39. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Van Bleek GM; Nathenson SG Nature; 1990 Nov; 348(6298):213-6. PubMed ID: 1700303 [TBL] [Abstract][Full Text] [Related]
40. The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study. Abualrous ET; Saini SK; Ramnarayan VR; Ilca FT; Zacharias M; Springer S PLoS One; 2015; 10(8):e0135421. PubMed ID: 26270965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]